Edwards Lifesciences Corp is an international medical technology provides domiciled in California, the United States.
The firm’s roots date back to 1958 when entrepreneur Miles ‘Lowell’ Edward aimed to build the first artificial heart. The 60-year-old engineer reportedly had 63 patents across various industries to his name. However, it was incorporated in September 1999.
The patient-focused medical company claims to have a strong presence in Puerto Rico, the United States, Singapore, Latin America, the Dominican Republic, etc. The company designs, manufactures, markets, and develops services and products related to late-stage cardiovascular disease. It operates in the global healthcare and medical equipment and devices sub industry.
The California-based firm trades as a public company on the New York Stock Exchange under the stock quote of ‘EW’.
The company claims to partner with several physicians and researches for innovating medical products to help the patients have a more productive, healthier and longer lives.
It reportedly focuses on developing cutting-edge latest medical technologies to addresses the large number of growing patient population and meet the unmet clinical needs. The technology and product offerings include repair products and tissue replacement heart valves systems, transcatheter heart valve for the patients who have a greater or higher risk of conventional valve replacement.
These heart and valve replacement systems involves rigorous scientific study, innovation, extensive clinical education and training, the medical tech firm claims. In addition, it claims to abide by high standard of ethical conduct based on the government standards of effective compliance programs.
The American company operates through several subsidiaries, namely Vapltech Cardio Ltd, Edward Lifesciences LTD, BMEYE BV, Edwards Life Science AG, EL Research CV, Zeppelin Zox Ltd, CardiAQ Valve Technologies Inc and Mitral Valve Technologies SARL. The company claims to be a global leader in medical innovation, which operates through a diversified team of experts such as critical care team, surgical team, TAVI heart team and hospital administration team.
There are various devices used in treating structural heart diseases and critical care, namely transcatheter heart valves, surgical valve repair, surgical valve replacement, hemodynamic monitoring, decision support software, pressure monitoring, and related accessories and instruments.
The American medical technology firm claims to provide several therapies for clot management, blood conservation, enhanced surgical recovery, infection control, etc.